NTRA logo

NTRA Natera, Inc.

NASDAQ Global Select · Medical - Diagnostics & Research · Healthcare

$273.40
-16.52 (-5.70%)

Natera, Inc. is a diagnostics company focused on developing and commercializing a wide array of molecular testing services globally. Its portfolio includes several key offerings: Panorama, a non-invasive prenatal test (NIPT) that screens for chromosomal abnormalities in a fetus using a blood sample from the mother, and also determines zygosity in twin pregnancies. Vistara, designed to identify sin…

Market Cap: $39.64Bwww.natera.com

Price

$322.10+65.39%
$186.36$231.61$276.85$322.10
Apr 29Aug 7

Social Signal Score

60
5d
64
3 mentions
+0.0%
30d
58
20 mentions
+0.0%
60d
59
29 mentions
+0.0%
90d
61
42 mentions
+0.0%
news: 24 · rss: 14 · marketaux: 4

Analyst Ratings

28 analysts
Buyconsensus
Strong Buy 0Buy 25Hold 3Sell 0Strong Sell 0
Avg price target$396.59+45.1%
Low $245Median $407.5High $500
Current Consensus

Revenue

$793.98M+1510.54%
$46.90M$295.93M$544.95M$793.98M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-2.40
$-2.61–$-2.19
10 analysts
FY2026
$-1.62
$-2.07–$-0.78
12 analysts
FY2027
$-0.52
$-1.12–$-0.04
12 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Solomon Moshkevich
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
6,138
Beta
1.51
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
26.83
www.natera.com